Today, Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- …
![Eva-Lotta Allan, Chair of Maxion Therapeutics Board](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/09/pexels-mart-production-7230192.jpg?resize=760%2C427&ssl=1)
![Eva-Lotta Allan, Chair of Maxion Therapeutics Board](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/09/pexels-mart-production-7230192.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Today, Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- …